Tokyo, November 24, 2010 - Astellas Pharma Inc. (headquarters: Tokyo; President and CEO: Masafumi Nogimori) today announced the new corporate name of merged production subsidiary. As announced on October 26.2010, it will merge its production subsidiaries in Japan, Astellas Tokai Co., Ltd. (headquarters: Yaizu, Shizuoka; president: Shunichi Hirashima) and Astellas Toyama Co., Ltd. (headquarters: Toyama,Toyama; president: Kinji Nakajima) and Astellas Pharma Chemicals Co., Ltd . (headquarters: Takahagi, Ibaraki; president: Motoyoshi Katano) on April 1, 2011.

(The new corporate name)
Astellas Pharma Tech Co., Ltd.

(Outline of the new company)
Date of establishment: January 25, 1986
Headquarters: 2-3-11, Nihonbashi-Honcho, Chuo-Ku, Tokyo, Japan 
Representative: Shunichi Hirashima 
Capital: \100 million
Total assets: \87,100 million(as of March 31,2010)
Number of employees: ca.1,720
Main businesses: manufacturing, marketing, import and export of drugs, etc.


Contact the Media Relations team
Communications & Investor Relations
Main phone line for Media: +81-3244-3201 
Business hours (JST)
From Monday to Thursday: 8:45 am to 5:45 pm, Friday: 8:45 am to 4:00 pm
(closed on Saturdays, Sundays, national holidays and company holidays)